Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

More documents

Recommendations

Info

12 GLOBAL DRUG FACILITY Commodity expenditure FLDs Figure 6 shows a 36% increase in the value of FLDs procured using Grant Procurement Services, (from $18 million in 2010 to $24.6 million in 2011). This represents a marked change from the plateau in grant funding between 2009 and 2010. In parallel there was a significant decrease between 2010 and 2011 (by 32%) of FLDs procured using Direct Procurement Services: for $33.5 million worth of FLDs in 2010 versus $22.7 million in 2011. It is likely that this reduction occurred because funding from the Global Fund was not available for procurement in a timely manner, which prompted requests for GDF emergency grants. SLDs To date, GDF has not provided grants for SLDs through its Technical Review Committee mechanism. SLDs have therefore been funded mostly by the Global Fund and through the UNITAID MDR-TB Project. Figure 7 shows a continual increase in the value of SLD orders during 2011. 2007 $13.5 $20.1 $33.6 2008 $14.0 $37.9 $51.9 2009 $20.6 $17.8 $38.4 2010 $33.5 $18.0 $51.5 2011 $22.7 $24.6 $47.3 Procurement value ( in millions of dollars ) Direct Direct procurement Procurement Grant Grant procurement Procurement Figure 6 Value of FLDs procured by year / funding source
13 ANNUAL REPORT 2011 80 70 60 Procurement value ( in millions of dollars ) 50 40 30 20 10 0 2009 2010 2011 WHO Unitaid MDR The Global Fund MSF KNCV Government Other Figure 7 Value of SLDs procured by year / funding source (all Direct Procurement Services)
Page 1 and 2: GLOBAL DRUG FACILITY ANNUAL REPORT
Page 3 and 4: Contents 02 | About the Global Drug
Page 5 and 6: 03 ANNUAL REPORT 2011 Message from
Page 7 and 8: 05 ANNUAL REPORT 2011 GDF was estab
Page 9 and 10: 07 ANNUAL REPORT 2011 Commodity exp
Page 11 and 12: 9 ANNUAL REPORT 2011 2010 GDF Grant
Page 13: 11 ANNUAL REPORT 2011 Historical an
Page 17 and 18: 15 ANNUAL REPORT 2011 2010 2011 Fre
Page 19 and 20: 17 ANNUAL REPORT 2011 There were ot
Page 21 and 22: 19 ANNUAL REPORT 2011 Diagnostics I
Page 23 and 24: 21 ANNUAL REPORT 2011 First-line dr
Page 25 and 26: 23 ANNUAL REPORT 2011 MDR-TB throug
Page 27 and 28: 25 ANNUAL REPORT 2011 Stockpile In
Page 29 and 30: 27 ANNUAL REPORT 2011 Key performan
Page 31 and 32: 29 ANNUAL REPORT 2011 Review • An
Page 33 and 34: 31 ANNUAL REPORT 2011 Monitoring mi
Page 35 and 36: 33 ANNUAL REPORT 2011 Annex 2 Patie
Page 37 and 38: 35 ANNUAL REPORT 2011 Country 2011
Page 39 and 40: 37 ANNUAL REPORT 2011 Country Suppl
Page 41 and 42: 39 ANNUAL REPORT 2011 WHO Region Co
Page 43 and 44: 41 ANNUAL REPORT 2011 Annex 5 GeneX
Page 45 and 46: 43 ANNUAL REPORT 2011 Countries rev
Page 48: Stop TB Partnership www.stoptb.org

Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?